Incorporation of camptothecin into N-phthaloyl chitosan-g-mPEG self-assembly micellar system

被引:79
作者
Opanasopit, Praneet [1 ]
Ngawhirunpat, Tanasait
Chaidedgumjorn, Amornrut
Rojanarata, Theerasak
Apirakaramwong, Auayporn
Phongying, Sasiprapha
Choochottiros, Chantiga
Chirachanchai, Suwabun
机构
[1] Silpakorn Univ, Fac Pharm, Dept Pharmaceut Technol, Nakhon Pathom 73000, Thailand
[2] Chulalongkorn Univ, Petr & Peotrochem Coll, Bangkok, Thailand
关键词
polymeric micelles; anticancer agent; camptothecin; N-phthaloylchitosan;
D O I
10.1016/j.ejpb.2006.06.001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The capability of N-phthaloylchitosan-grafted poly (ethylene glycol) methyl ether (mPEG)(PLC-g-mPEG) to enhance the aqueous solubility and stability of the lactone form of camptothecin (CPT) was investigated. PLC-g-mPEG formed a core-shell micellar structure after dialysis of the polymer solutions in dimethyl sulfoxide (DMSO) or dimethylformamide (DMF) against water, with a critical micelle concentration (CMC) of 28 mu g/ml. CPT was loaded into the inner core of the micelles by dialysis method. The results showed an increase in the CPT-loading amount with an increasing concentration of CPT. The stability of drug-loaded micelles was studied by gel-permeation chromatography (GPC), and their in vitro release behaviors were analyzed. Release of CPT from the micelles was sustained. When compared to the unprotected CPT, CPT-loaded PLC-g-mPEG micelles were able to prevent the hydrolysis of the lactone group of the drug. The kinetics of the CPT hydrolysis in human serum albumin (HSA) and fetal bovine serum (FBS) were pseudo-first order. The hydrolysis rate constants for CPT and CPT-loaded PLC-g-mPEG micelles in phosphate-buffered saline (PBS) pH 7.4, were 7.4 x 10(-3) min(-1) and 9.1 x 10(-3) h(-1), parallel to an increase in half-life of CPT from 94 min to 76.15 h, respectively. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:269 / 276
页数:8
相关论文
共 32 条
[1]  
Chow DSL, 2000, ANN NY ACAD SCI, V922, P164
[2]  
Conover CD, 1999, ANTI-CANCER DRUG DES, V14, P499
[3]   Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide [J].
Dharap, SS ;
Wang, Y ;
Chandna, P ;
Khandare, JJ ;
Qiu, B ;
Gunaseelan, S ;
Sinko, PJ ;
Stein, S ;
Farmanfarmaian, A ;
Minko, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (36) :12962-12967
[4]   Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides [J].
Dharap, SS ;
Qiu, B ;
Williams, GC ;
Sinko, P ;
Stein, S ;
Minko, T .
JOURNAL OF CONTROLLED RELEASE, 2003, 91 (1-2) :61-73
[5]   Poly(D,L-lactic-co-glycolic acid) microspheres for sustained delivery and stabilization of camptothecin [J].
Ertl, B ;
Platzer, P ;
Wirth, M ;
Gabor, F .
JOURNAL OF CONTROLLED RELEASE, 1999, 61 (03) :305-317
[6]   A KINETIC AND MECHANISTIC STUDY OF THE HYDROLYSIS OF CAMPTOTHECIN AND SOME ANALOGS [J].
FASSBERG, J ;
STELLA, VJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (07) :676-684
[7]   Macromolecular therapeutics - Advantages and prospects with special emphasis on solid tumour targeting [J].
Greish, K ;
Fang, J ;
Inutsuka, T ;
Nagamitsu, A ;
Maeda, H .
CLINICAL PHARMACOKINETICS, 2003, 42 (13) :1089-1105
[8]   ON THE MECHANISM OF TOPOISOMERASE-I INHIBITION BY CAMPTOTHECIN - EVIDENCE FOR BINDING TO AN ENZYME DNA COMPLEX [J].
HERTZBERG, RP ;
CARANFA, MJ ;
HECHT, SM .
BIOCHEMISTRY, 1989, 28 (11) :4629-4638
[9]   Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration [J].
Kawakami, S ;
Opanasopit, P ;
Yokoyama, M ;
Chansri, N ;
Yamamoto, T ;
Okano, T ;
Yamashita, F ;
Hashida, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 94 (12) :2606-2615
[10]   Improved dissolution and cytotoxicity of camptothecin incorporated into oxidized-cellulose microspheres prepared by spray drying [J].
Kumar, V ;
Kang, JC ;
Hohl, RJ .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2001, 6 (03) :459-467